Condition
Pleural Mesotheliomas clinical trials and research
Research outlook What's coming for Mesothelioma: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 2 Pleural Mesotheliomas clinical trials that are recruiting, in France. By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Fianlimab plus cemiplimab with chemotherapy for unresectable pleural mesothelioma
This study tests a combo of two immune therapies with chemotherapy to see if it helps people with newly diagnosed, unresectable pleural mesothelioma.
-
Ivonescimab for pleural mesothelioma that returned after immunotherapy and chemotherapy
This will try ivonescimab, a bispecific antibody targeting VEGF and PD‑1, as a second- or third-line treatment for people with pleural mesothelioma whose cancer progressed after immunotherapy and standard chemotherapy.
Related topics
Quick answers
How many Pleural Mesotheliomas clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in France. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.